COVID-19 vaccination coverage in hypertensive patients with Omicron infection: Comments on factors
Main Authors: | Hinpetch Daungsupawong, Viroj Wiwanitkit |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Human Vaccines & Immunotherapeutics |
Online Access: | https://www.tandfonline.com/doi/10.1080/21645515.2023.2285913 |
Similar Items
-
Immunogenicity of COVID-19 vaccines in patients with cirrhosis: Expected advantage for additional dose of vaccine
by: Hinpetch Daungsupawong, et al.
Published: (2024-12-01) -
Measles vaccine uptake and COVID-19
by: Hinpetch Daungsupawong, et al.
Published: (2023-08-01) -
COVID‐19 vaccine in liver transplant recipients
by: Hinpetch Daungsupawong, et al.
Published: (2024-03-01) -
ChatGPT and safety of COVID-19 vaccines
by: Hinpetch Daungsupawong, et al.
Published: (2023-08-01) -
Multi-epitope mRNA vaccine candidate to combat HMPV virus: Comment
by: Hinpetch Daungsupawong, et al.
Published: (2024-12-01)